Jonathon Mahlow, MD

Dr. Mahlow is a staff pathologist at ARUP and an assistant professor of pathology at the University of Utah School of Medicine. He received his MD from Wayne State School of Medicine in Detroit MI and completed his anatomic and clinical pathology residency training at the Cleveland Clinic Foundation in Cleveland OH. Subsequently, he completed a fellowship in surgical pathology at the University of Utah. Dr. Mahlow is a member of several professional societies, including the United States and Canadian Academy of Pathology, and the American Society for Clinical Pathology.

Olga Pozdnyakova, MD, PhD

Dr. Olga Pozdnyakova is an associate professor of pathology at Harvard Medical School and a diagnostic hematopathologist at Brigham and Women’s Hospital/Dana Farber Cancer Institute. She serves as the medical director of the Hematology Laboratory at Brigham and Women’s Hospital and Physician Diagnostics Labs at the Brigham Health Harbor Medical Associates. Dr. Pozdnyakova is an author of over 90 peer-reviewed publications and reviews. She has authored chapters on the topic of myeloid neoplasm in several fundamental pathology textbooks, such as Diagnostic Histopathology of Tumors, Wintrobe’s Atlas of Clinical Hematology, Diagnosis of Blood and Bone Marrow Disorders, and Diagnostic Bone Marrow Hematopathology, and is a coauthor of the textbook Hematopathology: A Volume in the High Yield Pathology Series. She serves as a vice-chair of the College of American Pathologists Clinical Hematology and Microscopy Committee. Dr. Pozdnyakova has lectured on various topics at numerous national and international pathology meetings and educational courses.

Jesse K. McKenney, MD

Dr. Jesse McKenney completed medical training at UT Southwestern Medical School, a pathology residency at Emory University, and a surgical pathology fellowship at Stanford University. He is currently vice-chair for faculty development in the Department of Pathology at the Cleveland Clinic, where he is a member of the gynecologic (GYN) and genitourinary (GU) subspecialty pathology sections, and has a busy general surgical pathology consultation service, specializing in esoteric and difficult-to-classify neoplasms. Dr. McKenney is coeditor of the 11th edition of Rosai and Ackerman’s Surgical Pathology. As the central reviewer for the Canary Prostate Active Surveillance (PASS) Study, his major academic interest is defining an optimal prognostic stratification system for use in active surveillance management.

Olga Pozdnyakova, MD, PhD

Dr. Olga Pozdnyakova is an associate professor of pathology at Harvard Medical School and a diagnostic hematopathologist at Brigham and Women’s Hospital/Dana Farber Cancer Institute. She serves as the medical director of the Hematology Laboratory at Brigham and Women’s Hospital and Physician Diagnostics Labs at the Brigham Health Harbor Medical Associates. Dr. Pozdnyakova is an author of over 90 peer-reviewed publications and reviews. She has authored chapters on the topic of myeloid neoplasm in several fundamental pathology textbooks, such as Diagnostic Histopathology of Tumors, Wintrobe’s Atlas of Clinical Hematology, Diagnosis of Blood and Bone Marrow Disorders, and Diagnostic Bone Marrow Hematopathology, and is a coauthor of the textbook Hematopathology: A Volume in the High Yield Pathology Series. She serves as a vice-chair of the College of American Pathologists Clinical Hematology and Microscopy Committee. Dr. Pozdnyakova has lectured on various topics at numerous national and international pathology meetings and educational courses.

Jesse K. McKenney, MD

Dr. Jesse McKenney completed medical training at UT Southwestern Medical School, a pathology residency at Emory University, and a surgical pathology fellowship at Stanford University. He is currently vice-chair for faculty development in the Department of Pathology at the Cleveland Clinic, where he is a member of the gynecologic (GYN) and genitourinary (GU) subspecialty pathology sections, and has a busy general surgical pathology consultation service, specializing in esoteric and difficult-to-classify neoplasms. Dr. McKenney is coeditor of the 11th edition of Rosai and Ackerman’s Surgical Pathology. As the central reviewer for the Canary Prostate Active Surveillance (PASS) Study, his major academic interest is defining an optimal prognostic stratification system for use in active surveillance management.

David P. Ng, MD

Dr. David P. Ng is a medical director of hematopathology at ARUP Laboratories and an assistant professor of pathology at the University of Utah. Dr. Ng received his medical degree from the University of Illinois at Chicago College of Medicine. He then completed an anatomic and clinical pathology residency at Dartmouth-Hitchcock Medical Center and a hematopathology fellowship at the University of Washington. Dr. Ng is board certified in anatomic and clinical pathology and hematology. He is the recipient of the Janis Giorgi Young Investigator award and the John H. Rippey Grant for Laboratory Quality Assurance. His research interests include minimal residual disease testing, clinical flow cytometry, and deep learning applications in flow cytometry.

Olga Pozdnyakova, MD, PhD

Dr. Olga Pozdnyakova is an associate professor of pathology at Harvard Medical School and a diagnostic hematopathologist at Brigham and Women’s Hospital/Dana Farber Cancer Institute. She serves as the medical director of the Hematology Laboratory at Brigham and Women’s Hospital and Physician Diagnostics Labs at the Brigham Health Harbor Medical Associates. Dr. Pozdnyakova is an author of over 90 peer-reviewed publications and reviews. She has authored chapters on the topic of myeloid neoplasm in several fundamental pathology textbooks, such as Diagnostic Histopathology of Tumors, Wintrobe’s Atlas of Clinical Hematology, Diagnosis of Blood and Bone Marrow Disorders, and Diagnostic Bone Marrow Hematopathology, and is a coauthor of the textbook Hematopathology: A Volume in the High Yield Pathology Series. She serves as a vice-chair of the College of American Pathologists Clinical Hematology and Microscopy Committee. Dr. Pozdnyakova has lectured on various topics at numerous national and international pathology meetings and educational courses.

Alejandro Sanchez, MD

Dr. Alejandro Sanchez is an assistant professor of urology at the University of Utah School of Medicine and a Huntsman Cancer Institute investigator. Dr. Sanchez specializes in the surgical care of patients with urologic cancers using open, laparoscopic, robotic, and endoscopic techniques. His practice at the Huntsman Cancer Institute primarily focuses on the multidisciplinary treatment of patients with prostate, bladder, kidney, testicular, adrenal, urethral, and penile cancers.

Dr. Sanchez received his undergraduate degree from the University of Florida where he graduated summa cum laude in biochemistry. He earned his medical degree from Harvard Medical School and completed his urologic surgery training at Massachusetts General Hospital. Dr. Sanchez then completed a fellowship in urologic oncology at Memorial Sloan Kettering Cancer Center where he received a Young Investigator Award from the American Society of Urologic Oncology to evaluate the mechanisms underlying the association of sarcopenia (low skeletal muscle mass) and poor oncologic outcomes in patients with clear cell renal cell carcinoma. During his fellowship, Dr. Sanchez also received the Chairman’s Award for Excellence in Basic Science.

Dr. Sanchez’s research efforts are primarily focused on clinical trial development and translational research.

Evan Raps, MD

Dr. Evan Raps is a medical director at ARUP Laboratories, and an assistant professor at the University of Utah School of Medicine. Dr. Raps completed his medical degree at the University of Nevada Medical School. He then completed his residency in anatomic and clinical pathology at the University of Utah School of Medicine as well as a residency in anatomic pathology at the University of Utah School of Medicine/ARUP Laboratories and a cytopathology fellowship at the University of Utah School of Medicine. Dr. Raps is certified by the American Board of Pathology. He specializes in cytopathology as well as head and neck pathology. His research interests include digital pathology.

Peng Li, MD, PhD

Dr. Peng Li is a medical director of hematopathology at ARUP Laboratories and an assistant professor at the University of Utah School of Medicine. Dr. Li received her doctorate degree in molecular pharmacology and structural biology from Thomas Jefferson University and her medical degree from Peking University Health Science Center. She then completed an anatomic and clinical pathology residency at the University of Utah School of Medicine. Following residency, Dr. Li completed a hematopathology fellowship at Stanford University and a molecular genetic pathology fellowship at Baylor College of Medicine. Dr. Li is board certified in anatomic and clinical pathology, molecular genetic pathology, and hematopathology. Her research interests include genetic aspects of myeloid and lymphoid malignancies and myeloid neoplasms with germline predisposition.

Deepika Sirohi, MD

Dr. Deepika Sirohi is a medical director of molecular oncology at ARUP Laboratories and an assistant professor at the University of Utah School of Medicine. Dr. Sirohi received her medical degree from the Armed Forces Medical College and then completed a residency in anatomic and clinical pathology at the University of Texas Health Science Center. She completed a genitourinary pathology fellowship at the Cedar-Sinai Medical Center and a molecular genetic pathology fellowship at the University of California. Dr. Sirohi is board certified in anatomic and clinical pathology and molecular genetic pathology. Her research interests include genomic alteration in urologic malignancies, viral oncogenesis, and applications of next generation sequencing to solid tumors.

Anna M. Shestakova, MD, PhD

Dr. Anna Shestakova is a medical director of Hematopathology and Molecular Genetic Pathology at ARUP Laboratories and an assistant professor (clinical) at the University of Utah School of Medicine. She received a medical degree from Bogomolets National Medical University and a doctorate degree from the University of Utah. She completed a residency in anatomical and clinical pathology at the University of California, Irvine School of Medicine, and she completed fellowships in hematopathology at the University of Michigan and molecular genetic pathology at the University of Utah School of Medicine. Dr. Shestakova is certified by the American Board of Pathology in anatomic and clinical pathology and hematopathology. She is also a member of the Educational Commission for Foreign Medical Graduates. Her research interests include small lymphocytic lymphoma (SLL), chronic lymphocytic leukemia (CLL), and the role of TP53 in the clonal evolution of lymphoid and myeloid neoplasms.

Deepika Sirohi, MD

Dr. Deepika Sirohi is a medical director of molecular oncology at ARUP Laboratories and an assistant professor at the University of Utah School of Medicine. Dr. Sirohi received her medical degree from the Armed Forces Medical College and then completed a residency in anatomic and clinical pathology at the University of Texas Health Science Center. She completed a genitourinary pathology fellowship at the Cedar-Sinai Medical Center and a molecular genetic pathology fellowship at the University of California. Dr. Sirohi is board certified in anatomic and clinical pathology and molecular genetic pathology. Her research interests include genomic alteration in urologic malignancies, viral oncogenesis, and applications of next generation sequencing to solid tumors.

Margaret Williams, MD

Dr. Margaret Williams is a medical director of Hematopathology at ARUP Laboratories, and an assistant professor (clinical) for the University of Utah School of Medicine. She received her medical degree from the University of North Carolina School of Medicine. She completed a residency in anatomic and clinical pathology from the University of Utah School of Medicine and a fellowship in hematopathology and molecular genetic pathology from the University of Utah School of Medicine. Dr. Williams is certified by the American Board of Pathology in anatomic and clinical pathology and hematopathology. Her research interests include molecular findings in hematologic malignancies and quality improvement.

Daniel Albertson, MD

Dr. Albertson is an associate professor of pathology at the University of Utah School of Medicine and currently serves as the Division Chief for Anatomic Pathology and Molecular Oncology. He previously served as the Section Head for Surgical Pathology as well as the head of Genitourinary Pathology. He received his MD from the University of Nebraska and completed his residency in anatomic and clinical pathology at Creighton University, followed by a surgical pathology fellowship at the University of Utah. While at Creighton, Dr. Albertson served as the chief resident for two years and received the Hal Lankford Pathology Resident Award. He is a member of United States and Canadian Academy of Pathology and the College of American Pathologists. Dr. Albertson’s special research interests include oncologic genitourinary, gynecologic, and solid tumor pathology.

Robert S. Ohgami, MD, PhD

Dr. Robert Ohgami is a chief medical director for Research and Development in integrated oncology and genetics at ARUP Laboratories, and a professor at the University of Utah School of Medicine. He received his medical degree at Harvard Medical School and his doctorate degree at Harvard University. Dr. Ohgami completed his residency in anatomic pathology and a fellowship in hematopathology from Stanford University. He is certified by the American Board of Pathology in anatomic pathology and hematology. Dr. Ohgami received the Berard-Dorfman Founders Award from the Society for Hematopathology. His research interests include translational molecular pathology, clinical laboratory testing, and hematopathology.

Jonathon Mahlow, MD

Dr. Mahlow is a staff pathologist at ARUP and an assistant professor of pathology at the University of Utah School of Medicine. He received his MD from Wayne State School of Medicine in Detroit MI and completed his anatomic and clinical pathology residency training at the Cleveland Clinic Foundation in Cleveland OH. Subsequently, he completed a fellowship in surgical pathology at the University of Utah. Dr. Mahlow is a member of several professional societies, including the United States and Canadian Academy of Pathology, and the American Society for Clinical Pathology.

Anton Rets, MD, PhD

Dr. Anton Rets is a medical director of hematopathology at ARUP Laboratories and an assistant professor at the University of Utah School of Medicine. Dr. Rets received a doctorate degree in pathology from Perm State Medical Academy/St. Petersburg Academy of Postgraduate Medical Education. He then earned his medical degree and completed a pathology residency at Perm State Medical Academy. He also completed an anatomic and clinical pathology residency at the State University of New York Downstate Medical Center before completing a hematopathology fellowship at the University of Utah School of Medicine. Dr. Rets is board certified in anatomic and clinical pathology and hematopathology. He has received several awards, including the Outstanding Teaching award in clinical pathology, the Excellence in Leadership award, and the Outstanding Academic Performance Federal award. His research interests include red blood cell disorders, nonneoplastic hematology, and digital microscopy.

Madhu P. Menon, MD, PhD

Dr. Madhu P. Menon, MD, is a medical director of hematopathology and an associate director professor at the University of Utah School of Medicine. Dr. Menon obtained his medical degree from Baroda Medical College, Maharaja Sayajirao University, and a doctorate degree in molecular medicine from the Huck Institute of Life Sciences, Pennsylvania State University. He then completed his anatomic and clinical pathology residency at the University of Massachusetts Medical School and hematopathology fellowships from the National Institutes of Health/National Cancer Institute, George Washington University Hospital, and Johns Hopkins University Hospital as well as a postdoctoral fellowship at the Maine Medical Center Research Institute. Dr. Menon is board certified in hematopathology, anatomic and clinical pathology. He also has a Lean Silver Certification, LEAN training for Healthcare Leaders. His research interests include diagnostic and prognostic markers in lymphomas, molecular characterization of lymphomas, and biomarkers for early detection of progression and transformation of low-grade lymphomas.

Marc Barry, MD

Dr. Marc Barry is a medical director of anatomic pathology at ARUP Laboratories and an associate professor at the University of Utah School of Medicine. He received his medical degree from University College Dublin before completing an anatomic pathology residency at the Brigham and Women’s Hospital. Following his residency, Dr. Barry completed a post-doctoral research fellowship at the Massachusetts Institute of Technology. He then continued on to finish both a medical renal pathology fellowship and a urologic pathology fellowship at Brigham and Women’s Hospital. Dr. Barry is board certified in anatomic pathology and is affiliated with several professional organizations, including the United States and Canadian Academy of Pathology, the American Society for Clinical Pathology, and the College of American Pathologists. He is also the recipient of multiple awards, including the Registrar’s Prize for Research from the Royal Academy of Medicine in Ireland, the Research Scholarship Award from the College of American Pathology Foundation, and for Excellence in Urologic Resident Education from the University of New Mexico. Dr. Barry’s research interests include clinicopathologic questions in medical renal and urologic pathology as well as epidemiologic and translation aspects of urologic neoplasia.

Marc Barry, MD

Dr. Marc Barry is a medical director of anatomic pathology at ARUP Laboratories and an associate professor at the University of Utah School of Medicine. He received his medical degree from University College Dublin before completing an anatomic pathology residency at the Brigham and Women’s Hospital. Following his residency, Dr. Barry completed a post-doctoral research fellowship at the Massachusetts Institute of Technology. He then continued on to finish both a medical renal pathology fellowship and a urologic pathology fellowship at Brigham and Women’s Hospital. Dr. Barry is board certified in anatomic pathology and is affiliated with several professional organizations, including the United States and Canadian Academy of Pathology, the American Society for Clinical Pathology, and the College of American Pathologists. He is also the recipient of multiple awards, including the Registrar’s Prize for Research from the Royal Academy of Medicine in Ireland, the Research Scholarship Award from the College of American Pathology Foundation, and for Excellence in Urologic Resident Education from the University of New Mexico. Dr. Barry’s research interests include clinicopathologic questions in medical renal and urologic pathology as well as epidemiologic and translation aspects of urologic neoplasia.